The microbiome of the built environment and mental health

Microbiome

Volumn 3, Issue 1, 2015, Pages

  Hoisington, Andrew J ^a   Brenner, Lisa A ^b   Kinney, Kerry A ^c   Postolache, Teodor T ^d   Lowry, Christopher A ^e  

^a UNITED STATES AIR FORCE ACADEMY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Bioinformed design; Built environment; Disease; Inflammation; Mental health; Microbiome; Neuropsychiatric disease; Psychiatric; Stress

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA;

AUTISM; DISEASE SEVERITY; DISEASE TRANSMISSION; DNA FINGERPRINTING; DNA SEQUENCE; ECOLOGY; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HOMEOSTASIS; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; MENTAL HEALTH; MICROBIAL DIVERSITY; MICROBIAL GROWTH; MICROBIOME; MICROFLORA; MUCOSAL MICROBIOME; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SKIN MICROBIOME; STAPHYLOCOCCUS AUREUS; STRESS; ENVIRONMENTAL PLANNING; MICROBIOLOGY; MICROCLIMATE; PSYCHOLOGY; SICK BUILDING SYNDROME;

ENVIRONMENT DESIGN; ENVIRONMENT, CONTROLLED; HUMANS; INFLAMMATION; MENTAL HEALTH; MICROBIOTA; SICK BUILDING SYNDROME;

EID: 84975096590     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/s40168-015-0127-0     Document Type: Review

References (171)

1. Evans GW. The built environment and mental health. J Urban Health. 2003;80(4):536-55. doi:10.1093/jurban/jtg063.
2. Meadow JF, Altrichter AE, Kembel SW, Kline J, Mhuireach G, Moriyama M, et al. Indoor airborne bacterial communities are influenced by ventilation, occupancy, and outdoor air source. Indoor Air. 2013;24(1):41-8. doi:10.1111/ina.12047.
3. Kembel SW, Meadow JF, O'Connor TK, Mhuireach G, Northcutt D, Kline J, et al. Architectural design drives the biogeography of indoor bacterial communities. PLoS One. 2014;9(1):e87093. doi:10.1371/journal.pone.0087093.
4. Relman DA, Gilbert JA, Knight R. The promise of the microbiome: function and dysfunction in humans and beyond. Science. 2014;345(6193):226. doi:10.1126/science.345.6193.226-c.
5. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al. Ultra-high-throughput microbial community analysis on the illumina HiSeq and MiSeq platforms. ISME J. 2012;6(8):1621-4. doi:10.1038/ismej.2012.8.
6. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335-6. doi:10.1038/nmeth.f.303.
7. Forsberg A, Abrahamsson TR, Bjorksten B, Jenmalm MC. Pre-and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy. 2013;43(4):434-42. doi:10.1111/cea.12082.
8. Forsythe P, Inman MD, Bienenstock J. Oral treatment with live lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med. 2007;175(6):561-9. doi:10.1164/rccm.200606-821OC.
9. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteriinduced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 2009;179(3):186-93. doi:10.1164/rccm.200806-951OC.
10. Miniello VL, Brunetti L, Tesse R, Natile M, Armenio L, Francavilla R. Lactobacillus reuteri modulates cytokines production in exhaled breath condensate of children with atopic dermatitis. J Pediatr Gastroenterol Nutr. 2010;50(5):573-6. doi:10.1097/MPG.0b013e3181bb343f.
11. Belkaid Y, Segre JA. Dialogue between skin microbiota and immunity. Science. 2014;346(6212):954-9. doi:10.1126/science.1260144.
12. Horai R, Zárate-Bladés Carlos R, Dillenburg-Pilla P, Chen J, Kielczewski Jennifer L, Silver Phyllis B, et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity. 2015;43(2):343-53. doi:10.1016/j.immuni.2015.07.014.
13. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6:263. doi:10.1126/scitranslmed.3009759.
14. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011;108:4615-22. doi:10.1073/pnas.1000082107.
15. Gareau MG. Microbiota-gut-brain axis and cognitive function. In: Lyte M, Cryan JF, editors. Microbial endocrinology: the microbiota-gut-brain axis in health and disease. advances in experimental medicine and biology. 2014. p. 357-71.
16. Smith CJ, Emge JR, Berzins K, Lung L, Khamishon R, Shah P, et al. Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice. Am J Physiol Gastrointest Liver Physiol. 2014;307(8):G793-802. doi:10.1152/ajpgi.00238.2014.
17. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050-5. doi:10.1073/pnas.1102999108.
18. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23:3. doi:10.1111/j.1365-2982.2010.01620.x.
19. Heijtza RD, Wang SG, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047-52. doi:10.1073/pnas.1010529108.
20. Felger JC, Lotrich FE. Inflammatory cytokines in depression: nuerobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199-229. doi:10.1016/j.neuroscience.2013.04.060.
21. Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137-62. doi:10.1038/npp.2011.205.
22. Miller AH, Raison CL. Are anti-inflammatory therapies viable treatments for psychiatric disorders? Where the rubber meets the road. JAMA Psychiatry. 2015;72(6):527-8. doi:10.1001/jamapsychiatry.2015.22.
23. Raison CL, Lowry CA, Rook GAW. Inflammation, sanitation, and consternation loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry. 2010;67(12):1211-24. doi:10.1001/archgenpsychiatry.2010.161.
24. Rook GAW, Raison CL, Lowry CA. Childhood microbial experience, immunoregulation, inflammation and adult susceptibility to psychosocial stressors and depression in rich and poor countries. Evol Med Public Health. 2013;2013(1):14-7. doi:10.1093/emph/eos005.
25. Rook GA, Raison CL, Lowry CA. Microbial 'old friends', immunoregulation and socioeconomic status. Clin Exp Immunol. 2014;177(1):1-12.
26. Rook GAW, Raison CL, Lowry CA. Microbiota, immunoregulatory old friends and psychiatric disorders. In: Lyte M, Cryan JF, editors. microbial endocrinology: the microbiota-gut-brain axis in health and disease. Advances in experimental medicine and biology. 2014. p. 319-56.
27. Rook GAW, Lowry CA. The hygiene hypothesis and psychiatric disorders. Trends Immunol. 2008;29(4):150-8. doi:10.1016/j.it.2008.01.002.
28. McFall-Ngai M, Hadfield MG, Bosch TCG, Carey HV, Domazet-Loso T, Douglas AE, et al. Animals in a bacterial world, a new imperative for the life sciences. Proc Natl Acad Sci U S A. 2013;110(9):3229-36. doi:10.1073/pnas.1218525110.
29. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31(4):677-89. doi:10.1016/j.immuni.2009.08.020.
30. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science. 2011;331(6015):337-41. doi:10.1126/science.1198469.
31. Round JL, Mazmanian SK. Inducible foxp(3+) regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107(27):12204-9. doi:10.1073/pnas.0909122107.
32. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature. 2007;447(7142):279-83. doi:10.1038/nature05775.
33. Rook GA. Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health. Proc Natl Acad Sci U S A. 2013;110(46):18360-7.
34. Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson W, Braun-Fahrlander C, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701-9. doi:10.1056/NEJMoa1007302.
35. Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A. 2012;109(21):8334-9. doi:10.1073/pnas.1205624109.
36. Clemente JC, Pehrsson EC, Blaser MJ, Sandhu K, Gao Z, Wang B, et al. The microbiome of uncontacted Amerindians. Sci Adv. 2015;1:3.
37. Martinez I, Stegen JC, Maldonado-Gomez MX, Eren AM, Siba PM, Greenhill AR, et al. The gut microbiota of rural Papua New Guineans: composition, diversity patterns, and ecological processes. Cell Rep. 2015;11(4):527-38. doi:10.1016/j.celrep.2015.03.049.
38. Martin LJ, Adams RL, Bateman A, Bik HM, Hawks J, Hird SM, et al. Evolution of the indoor biome. Trends Ecol Evol. 2015;30(4):223-32. doi:10.1016/j.tree.2015.02.001.
39. Klepeis NTA, Behar JV. Analysis of the National Human Activity Pattern Survey (NHAPS) respondents from a standpoint of exposure assessment. Las Vegas: Laboratory USEPANER; 1996.
40. Weschler CJ. Changes in indoor pollutants since the 1950s. Atmos Environ. 2009;43(1):153-69. doi:10.1016/j.atmosenv.2008.09.044.
41. Cautley D, Viner J, Lord M, Pearce M. Test methods and protocols for environmental and safety hazards associated with home energy retrofits. Golden: US Department of Energy, Energy Efficiency & Renewable Energy, Building Technologies Program; 2012.
42. Sanders D. Arrival city. New York: Random House; 2012.
43. Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol. 1962;17(12):827.
44. Rosenthal D. Genetic theory and abnormal behavior. New York: McGraw-Hill; 1970.
45. McDade TW, Rutherford J, Adair L, Kuzawa CW. Early origins of inflammation: microbial exposures in infancy predict lower levels of Creactive protein in adulthood. Proc Biol Sci. 2010;277(1684):1129-37. doi:10.1098/rspb.2009.1795.
46. Chehoud C, Rafail S, Tyldsley AS, Seykora JT, Lambris JD, Grice EA. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc Natl Acad Sci. 2013;110(37):15061-6. doi:10.1073/pnas.1307855110.
47. Garcia-Garcera M, Coscolla M, Garcia-Etxebarria K, Martin-Caballero J, Gonzalez-Candelas F, Latorre A, et al. Staphylococcus prevails in the skin microbiota of long-term immunodeficient mice. Environ Microbiol. 2012;14(8):2087-98. doi:10.1111/j.1462-2920.2012.02756.x.
48. Kelley ST, Gilbert JA. Studying the microbiology of the indoor environment. Genome Biol. 2013;14:2. doi:10.1186/gb-2013-14-2-202.
49. Nielsen KM, Johnsen PJ, Bensasson D, Daffonchio D. Release and persistence of extracellular DNA in the environment. Environ Biosafety Res. 2007;6(1-2):37-53.
50. Hunt JR, Martinelli R, Adams VC, Rook GA, Brunet LR. Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. Clin Exp Allergy. 2005;35(5):685-90.
51. Nocker A, Sossa KE, Camper AK. Molecular monitoring of disinfection efficacy using propidium monoazide in combination with quantitative PCR. J Microbiol Methods. 2007;70(2):252-60. doi:10.1016/j.mimet.2007.04.014.
52. Nocker A, Sossa-Fernandez P, Burr MD, Camper AK. Use of propidium monoazide for live/dead distinction in microbial ecology. Appl Environ Microbiol. 2007;73(16):5111-7. doi:10.1128/AEM.02987-06.
53. Exterkate RAM, Zaura E, Brandt BW, Buijs MJ, Koopman J, Crielaard W, et al. The effect of propidium monoazide treatment on the measured bacterial composition of clinical samples after the use of a mouthwash. Clin Oral Investig. 2015;19(4):813-22. doi:10.1007/s00784-014-1297-z.
54. Ramos T, Dedesko S, Siegel JA, Gilbert JA, Stephens B. Spatial and temporal variations in indoor environmental conditions, human occupancy, and operational characteristics in a new hospital building. PLoS One. 2015;10:3. doi:10.1371/journal.pone.0118207.
55. Wood M, Gibbons S, Lax S, Eshoo-Anton T, Owens S, Kennedy S, et al. Athletic equipment microbiota are shaped by interactions with human skin. Microbiome. 2015;3(1):25. doi:10.1186/s40168-015-0088-3.
56. Lax S, Nagler CR, Gilbert JA. Our interface with the built environment: immunity and the indoor microbiota. Trends Immunol. 2015;36(3):121-3. doi:10.1016/j.it.2015.01.001.
57. Lax S, Smith DP, Hampton-Marcell J, Owens SM, Handley KM, Scott NM, et al. Longitudinal analysis of microbial interaction between humans and the indoor environment. Science. 2014;345(6200):1048-52. doi:10.1126/science.1254529.
58. Flores GE, Bates ST, Caporaso JG, Lauber CL, Leff JW, Knight R, et al. Diversity, distribution and sources of bacteria in residential kitchens. Environ Microbiol. 2013;15(2):588-96. doi:10.1111/1462-2920.12036.
59. Brauer SL, Vuono D, Carmichael MJ, Pepe-Ranney C, Strom A, Rabinowitz E, et al. Microbial sequencing analyses suggest the presence of a fecal veneer on indoor climbing wall holds. Curr Microbiol. 2014;69(5):681-9. doi:10.1007/s00284-014-0643-3.
60. Hospodsky D, Qian J, Nazaroff WW, Yamamoto N, Bibby K, Rismani-Yazdi H, et al. Human occupancy as a source of indoor airborne bacteria. PLoS One. 2012;7(4):e34867. doi:10.1371/journal.pone.0034867.
61. Qian J, Hospodsky D, Yamamoto N, Nazaroff WW, Peccia J. Size-resolved emission rates of airborne bacteria and fungi in an occupied classroom. Indoor Air. 2012;22:339-51. doi:10.1111/j.1600-0668.2012.00769.x.
62. Oh J, Byrd AL, Deming C, Conlan S, Program NCS, Kong HH, et al. Biogeography and individuality shape function in the human skin metagenome. Nature. 2014;514(7520):59-64. doi:10.1038/nature13786.
63. Moore MN. Do airborne biogenic chemicals interact with the PI3K/Akt/mTOR cell signalling pathway to benefit human health and wellbeing in rural and coastal environments? Environ Res. 2015;140:65-75. doi:10.1016/j.envres.2015.03.015.
64. Panzer AR, Lynch SV. Influence and effect of the human microbiome in allergy and asthma. Curr Opin Rheumatol. 2015;27(4):373-80. doi:10.1097/BOR.0000000000000191.
65. Fujimura KE, Lynch SV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015;17(5):592-602. doi:10.1016/j.chom.2015.04.00.
66. Sanford JA, Gallo RL. Functions of the skin microbiota in health and disease. Semin Immunol. 2013;25(5):370-7. doi:10.1016/j.smim.2013.09.005.
67. SanMiguel A, Grice E. Interactions between host factors and the skin microbiome. Cell Mol Life Sci. 2015;72(8):1499-515. doi:10.1007/s00018-014-1812-z.
68. Halstrom S, Price P, Thomson R. Review: environmental mycobacteria as a cause of human infection. Int J Mycobacteriol. 2015;4(2):81-91. doi:10.1016/j.ijmyco.2015.03.002.
69. Thomson R, Tolson C, Carter R, Coulter C, Huygens F, Hargreaves M. Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol. 2013;51(9):3006-11. doi:10.1128/jcm.00899-13.
70. van Heijnsbergen E, Schalk JAC, Euser SM, Brandsema PS, den Boer JW, Husman AMD. Confirmed and potential sources of Legionella reviewed. Environ Sci Technol. 2015;49(8):4797-815. doi:10.1021/acs.est.5b00142.
71. Tyndall RL, Lehman ES, Bowman EK, Milton DK, Barbaree JM. Home humidifiers as a potential source of exposure to microbial pathogens, endotoxins, and allergens. Indoor Air Int J Indoor Air Qual Clim. 1995;5(3):171-8. doi:10.1111/j.1600-0668.1995.t01-1-00003.x.
72. Krogulska B, Matuszewska R, Krogulski A, Szczotko M, Bartosik M, Maziarka D, et al. Occurrence of Legionella in technological water and studies of the total number of bacteria and fungi in indoor air at workplaces where water aerosol is generated. Med Pr. 2014;65(3):325-34.
73. Hull NM, Reens AL, Robertson CE, Stanish LF, Harris JK, Stevens MJ, et al. Molecular analysis of single room humidifier bacteriology. Water Res. 2015;69:318-27. doi:10.1016/j.watres.2014.11.024.
74. Lee JH, Ahn KH, Yu IJ. Outbreak of bioaerosols with continuous use of humidifier in apartment room. Toxicol Res. 2012;28(2):103-6. doi:10.5487/tr.2012.28.2.103.
75. Uhlemann AC, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MTG, et al. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci U S A. 2014;111(18):6738-43. doi:10.1073/pnas.1401006111.
76. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4):e35797. doi:10.1371/journal.pone.0035797.
77. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7. doi:10.1038/nature12060.
78. Green JL. Can bioinformed design promote healthy indoor ecosystems? Indoor Air. 2014;24(2):113-5. doi:10.1111/ina.12090.
79. Legatzki A, Rosler B, von Mutius E. Microbiome diversity and asthma and allergy risk. Curr Allergy Asthma Rep. 2014;14:10. doi:10.1007/s11882-014-0466-0.
80. Hoang CP, Kinney KA, Corsi RL, Szaniszlo PJ. Resistance of green building materials to fungal growth. Int Biodeter Biodegr. 2010;64(2):104-13. doi:10.1016/j.ibiod.2009.11.001.
81. Grant C, Hunter CA, Flannigan B, Bravery AF. The moisture requirements of moulds isolated from domestic dwellings. Int Biodeterior. 1989;25(4):259-84. doi:10.1016/0265-3036(89)90002-x.
82. Verdier T, Coutand M, Bertron A, Roques C. A review of indoor microbial growth across building materials and sampling and analysis methods. Build Environ. 2014;80:136-49. doi:10.1016/j.buildenv.2014.05.030.
83. Arnold C. Rethinking sterile: the hospital microbiome. Environ Health Perspect. 2014;122(7):A182-7. doi:10.1289/ehp.122-A182.
84. Lax S, Gilbert JA. Hospital-associated microbiota and implications for nosocomial infections. Trends Mol Med. 2015;21(7):427-32. doi:10.1016/j.molmed.2015.03.005.
85. Kembel SW, Jones E, Kline J, Northcutt D, Stenson J, Womack AM, et al. Architectural design influences the diversity and structure of the built environment microbiome. ISME J. 2012;1-11. doi:10.1038/ismej.2011.211.
86. Logan AC. Dysbiotic drift: mental health, environmental grey space, and microbiota. J Physiol Anthropol. 2015;34(1):015-0061.
87. Schloss P, Iverson K, Petrosino J, Schloss S. The dynamics of a family's gut microbiota reveal variations on a theme. Microbiome. 2014;2(1):25. doi:10.1186/2049-2618-2-25.
88. Napoli C, Marcotrigiano V, Montagna MT. Air sampling procedures to evaluate microbial contamination: a comparison between active and passive methods in operating theatres. BMC Public Health. 2012;12:594. doi:10.1186/1471-2458-12-594.
89. Chuaybamroong P, Choomseer P, Sribenjalux P. Comparison between hospital single air unit and central air unit for ventilation performances and airborne microbes. Aerosol Air Qual Res. 2008;8(1):28-36.
90. French GL, Otter JA, Shannon KP, Adams NMT, Watling D, Parks MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect. 2004;57(1):31-7. doi:10.1016/j.jhin.2004.03.006.
91. Rutala WA, Weber DJ. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev. 1997;10(4):597-610.
92. Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG, et al. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One. 2014;9:9. doi:10.1371/journal.pone.0108598.
93. Chang CW, Li SY, Huang SH, Huang CK, Chen YY, Chen CC. Effects of ultraviolet germicidal irradiation and swirling motion on airborne Staphylococcus aureus, Pseudomonas aeruginosa and Legionella pneumophila under various relative humidities. Indoor Air. 2013;23(1):74-84. doi:10.1111/j.1600-0668.2012.00793.x.
94. Mphaphlele M, Dharmadhikari AS, Jensen PA, Rudnick SN, van Reenen TH, Pagano MA, et al. Institutional tuberculosis transmission controlled trial of upper room ultraviolet air disinfection: a basis for new dosing guidelines. Am J Respir Crit Care Med. 2015;192(4):477-84. doi:10.1164/rccm.201501-0060OC.
95. Hones K, Stangl F, Sift M, Hessling M. Visible optical radiation generates bactericidal effect applicable for inactivation of health care associated germs demonstrated by inactivation of E. coli and B. subtilis using 405 nm and 460 nm light emitting diodes. Novel Biophotonics Techn Appl III. 2015;9540. doi:10.1117/12.2183903.
96. Miller SL. Upper room germicidal ultraviolet systems for air disinfection are ready for wide implementation. Am J Respir Crit Care Med. 2015;192(4):407-9. doi:10.1164/rccm.201505-0927ED.
97. Lax S, Hampton-Marcell J, Gibbons S, Colares G, Smith D, Eisen J, et al. Forensic analysis of the microbiome of phones and shoes. Microbiome. 2015;3(1):21. doi:10.1186/s40168-015-0082-9.
98. Meadow JF, Altrichter AE, Green JL. Mobile phones carry the personal microbiome of their owners. PeerJ. 2014;24:2. doi:10.7717/peerj.447.
99. Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJM, et al. Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci. 2015;112(22):E2930-8. doi:10.1073/pnas.1423854112.
100. Fond G, Kuin A, Koeter MW, Lutter R, van Gool T, Yolken R, et al. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand. 2015;132(3):161-79. doi:10.1111/acps.12423.
101. Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry. 2012;69(11):1123-30. PubMed PMID: 22752117.
102. Cook TB, Brenner LA, Cloninger CR, Langenberg P, Igbide A, Giegling I, et al. "Latent" infection with Toxoplasma gondii: association with trait aggression and impulsivity in healthy adults. J Psychiatr Res. 2015;60:87-94. doi:10.1016/j.jpsychires.2014.09.019. Epub 2014 Sep 28. PubMed PMID: 25306262.
103. Jones JL, Kruszon-Moran D, Rivera HN, Price C, Wilkins PP. Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014;90(6):1135-9. doi:10.4269/ajtmh.14-0013.
104. Frenkel JK, Lindsay DS, Parker BB, Dobesh M. Dogs as possible mechanical carriers of Toxoplasma, and their fur as a source of infection of young children. Int J Infect Dis. 2003;7(4):292-3.
105. Holmes CJ, Plichta JK, Gamelli RL, Radek KA. Dynamic role of host stress responses in modulating the cutaneous microbiome: implications for wound healing and infection. Adv Wound Care. 2015;4(1):24-37. doi:10.1089/wound.2014.0546.
106. Schmidt C. Mental health: thinking from the gut. Nature. 2015;518(7540):S12-5. doi:10.1038/518S13a.
107. Clarke G, O'Mahony S, Dinan T, Cryan J. Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour. Acta Paediatr. 2014;103(8):812-9. doi:10.1111/apa.12674.
108. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010;5(5):e10667. doi:10.1371/journal.pone.0010667.
109. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev. 2004;17(4):863-93. doi:10.1128/cmr.17.4.863-893.2004.
110. Kramer M, Obermajer N, Bogovic Matijasic B, Rogelj I, Kmetec V. Quantification of live and dead probiotic bacteria in lyophilised product by real-time PCR and by flow cytometry. Appl Microbiol Biotechnol. 2009;84(6):1137-47. doi:10.1007/s00253-009-2068-7.
111. Consortium THMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-14. doi:10.1038/nature11234.
112. Foster JA, McVey Neufeld K-A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-12. doi:10.1016/j.tins.2013.01.005.
113. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther. 2015;37(5):984-95. doi:10.1016/j.clinthera.2015.04.002.
114. Luna RA, Foster JA. Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr Opin Biotechnol. 2015;32:35-41. doi:10.1016/j.copbio.2014.10.007.
115. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-12. doi:10.1038/nrn3346.
116. Bilbo SD, Nevison CD, Parker W. A model for the induction of autism in the ecosystem of the human body: the anatomy of a modern pandemic? Microb Ecol Health Dis. 2015;26:26253. doi:10.3402/mehd.v26.26253.
117. Toh MC, Allen-Vercoe E. The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts. Microb Ecol Health Dis. 2015;26:26309. doi:10.3402/mehd.v26.26309.
118. Krajmalnik-Brown R, Lozupone C, Kang DW, Adams JB. Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease. Microb Ecol Health Dis. 2015;26:26914. doi:10.3402/mehd.v26.26914.
119. Collins CH, Grange JM, Yates MD. Mycobacteria in water. J Appl Bacteriol. 1984;57(2):193-211. doi:10.1111/j.1365-2672.1984.tb01384.x.
120. Stanford J, Paul R. A preliminary report on some studies of environmental mycobacteria from Uganda. Ann Soc Belg Med Trop. 1973;53:389-93.
121. Primm TP, Lucero CA, Falkinham JO. Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17(1):98-106. doi:10.1128/cmr.17.1.98-106.2004.
122. Jin BW, Saito H, Yoshii Z. Environmental mycobacteria in Korea. Microbiol Immunol. 1984;28(6):667-77. doi:10.1111/j.1348-0421.1984.tb00721.x.
123. Pontiroli A, Khera TT, Oakley BB, Mason S, Dowd SE, Travis ER, et al. Prospecting environmental mycobacteria: combined molecular approaches reveal unprecedented diversity. PLoS One. 2013;8(7):e68648. doi:10.1371/journal.pone.0068648.
124. Gcebe N, Rutten V, Gey van Pittius NC, Michel A. Prevalence and distribution of non-tuberculous mycobacteria (NTM) in cattle, African buffaloes (Syncerus caffer) and their environments in South Africa. Transbound Emerg Dis. 2013;60:74-84. doi:10.1111/tbed.12133.
125. Kamala T, Paramasivan CN, Herbert D, Venkatesan P, Prabhakar R. Isolation and identification of environmental mycobacteria in the mycobacterium bovis BCG trial area of south India. Appl Environ Microbiol. 1994;60(6):2180-3.
126. Kamala T, Paramasivan CN, Herbert D, Venkatesan P, Prabhakar R. Evaluation of procedures for isolation of nontuberculous mycobacteria from soil and water. Appl Environ Microbiol. 1994;60(3):1021-4.
127. Adrados B, Julián E, Codony F, Torrents E, Luquin M, Morató J. Prevalence and concentration of non-tuberculous mycobacteria in cooling towers by means of quantitative PCR: a prospective study. Curr Microbiol. 2011;62(1):313-9. doi:10.1007/s00284-010-9706-2.
128. Pryor M, Springthorpe S, Riffard S, Brooks T, Huo Y, Davis G, et al. Investigation of opportunistic pathogens in municipal drinking water under different supply and treatment regimes. Water Sci Technol. 2004;50(1):83-90.
129. van Ingen J, Blaak H, de Beer J, de Roda Husman AM, van Soolingen D. Rapidly growing nontuberculous mycobacteria cultured from home tap and shower water. Appl Environ Microbiol. 2010;76(17):6017-9. doi:10.1128/aem.00843-10.
130. Torvinen E, Meklin T, Torkko P, Suomalainen S, Reiman M, Katila M-L, et al. Mycobacteria and fungi in moisture-damaged building materials. Appl Environ Microbiol. 2006;72(10):6822-4. doi:10.1128/aem.00588-06.
131. Sussland Z, Prochazkva V. Atypical mycobacteria isolated from terrarium from zoological garden in Prague. Veterinarstvi (in Czech). 1975;25:320-2.
132. Lavania M, Katoch K, Parashar D, Sharma P, Das R, Chauhan D, et al. 2 predominance of Mycobacterium fortuitum-chelonae complex in Ghatampur field area, endemic for leprosy. Indian J Lepr. 2008;80(4):323.
133. Hernández AS, Torres MG, Molina JA, Amat GC. Biodegradation potential and molecular detection of the cathecol 1, 2-dioxygenase gene of actinobacteria isolated from wastewater treatment plants in Spain. Microbes in applied research: current advances and challenges. Singapore: World Scientific Publishing Co; 2015.
134. O'Brien MER, Anderson H, Kaukel E, O'Byrne K, Pawlicki M, von Pawel J, et al. SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol. 2004;15(6):906-14. doi:10.1093/annonc/mdh220.
135. Lowry CA, Hollis JH, de Vries A, Pan B, Brunet LR, Hunt JRF, et al. Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience. 2007;146(2):756-72. doi:10.1016/j.neuroscience.2007.01.067.
136. Matthews DM, Jenks SM. Ingestion of Mycobacterium vaccae decreases anxiety-related behavior and improves learning in mice. Behav Processes. 2013;96:27-35. doi:10.1016/j.beproc.2013.02.007.
137. Bonjoch X, Ballesté E, Blanch AR. Multiplex PCR with 16S rRNA genetargeted primers of Bifidobacterium spp. To identify sources of fecal pollution. Appl Environ Microbiol. 2004;70(5):3171-5. doi:10.1128/aem.70.5.3171-3175.2004.
138. Savignac HM, Tramullas M, Kiely B, Dinan TG, Cryan JF. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res. 2015;287:59-72. doi:10.1016/j.bbr.2015.02.044.
139. Savignac HM, Kiely B, Dinan TG, Cryan JF. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil. 2014;26(11):1615-27. doi:10.1111/nmo.12427.
140. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170(4):1179-88. doi:10.1016/j.neuroscience.2010.08.005.
141. Messaoudi M, Violle N, Bisson J-F, Desor D, Javelot H, Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2011;2(4):256-61. doi:10.4161/gmic.2.4.16108.
142. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105(05):755-64.
143. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23(12):1132-9. doi:10.1111/j.1365-2982.2011.01796.x.
144. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139(6):2102-2112.e1. doi:10.1053/j.gastro.2010.06.063.
145. Hong P-Y, Wu J-H, Liu W-T. Relative abundance of Bacteroides spp. in stools and wastewaters as determined by hierarchical oligonucleotide primer extension. Appl Environ Microbiol. 2008;74(9):2882-93. doi:10.1128/aem.02568-07.
146. Hsiao Elaine Y, McBride Sara W, Hsien S, Sharon G, Hyde Embriette R, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451-63. doi:10.1016/j.cell.2013.11.024.
147. Yang H, Zhao X, Tang S, Huang H, Zhao X, Ning Z, et al. Probiotics reduce psychological stress in patients before laryngeal cancer surgery. Asia Pac J Clin Oncol. 2014; doi:10.1111/ajco.12120.
148. Castillo-Rojas G, Mazari-Hiríart M, Ponce de León S, Amieva-Fernández RI, Agis-Juárez RA, Huebner J, et al. Comparison of enterococcus faecium and enterococcus faecalis strains isolated from water and clinical samples: antimicrobial susceptibility and genetic relationships. PLoS One. 2013;8(4):e59491. doi:10.1371/journal.pone.0059491.
149. Divyashri G, Krishna G, Muralidhara M, Prapulla SG. Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of probiotic Enterococcus faecium CFR 3003: in vitro and in vivo evidences. J Med Microbiol. 2015;7(10):000184. doi:10.1099/jmm.0.000184.
150. Bernardeau M, Guguen M, Vernoux JP. Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbiol Rev. 2006;30(4):487-513. doi:10.1111/j.1574-6976.2006.00020.x.
151. Flores GE, Bates ST, Knights D, Lauber CL, Stombaugh J, Knight R, et al. Microbial biogeography of public restroom surfaces. PLoS One. 2011;6(11):e28132. doi:10.1371/journal.pone.0028132.
152. Rao A, Bested A, Beaulne T, Katzman M, Iorio C, Berardi J, et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens. 2009;1(1):1-6. doi:10.1186/1757-4749-1-6.
153. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2006;61(3):355-61.
154. Vitali B, Minervini G, Rizzello CG, Spisni E, Maccaferri S, Brigidi P, et al. Novel probiotic candidates for humans isolated from raw fruits and vegetables. Food Microbiol. 2012;31(1):116-25. doi:10.1016/j.fm.2011.12.027.
155. Schillinger U, Holzapfel W. The genus Lactobacillus. In: The genera of lactic acid bacteria. New York: Springer; 1995. p. 19-54.
156. Hewitt KM, Gerba CP, Maxwell SL, Kelley ST. Office space bacterial abundance and diversity in three metropolitan areas. PLoS One. 2012;7(5):e37849. doi:10.1371/journal.pone.0037849.
157. Wang T, Hu X, Liang S, Li W, Wu X, Wang L, et al. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benefic Microbes. 2015;6(5):707-17. doi:10.3920/BM2014.0177.
158. Luo J, Wang T, Liang S, Hu X, Li W, Jin F. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci. 2014;57(3):327-35. doi:10.1007/s11427-014-4615-4.
159. Liang S, Wang T, Hu X, Luo J, Li W, Wu X, et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience. 2015;310:561-77. doi:10.1016/j.neuroscience.2015.09.033.
160. Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, et al. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 2013;38(9):1738-47. doi:10.1016/j.psyneuen.2013.02.008.
161. Smith CJ, Emge JR, Berzins K, Lung L, Khamishon R, Shah P, et al. Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice. Am J Physiol Gastrointest Liver Physiol. 2014;307(8):4. doi:10.1152/ajpgi.00238.2014.
162. Woo J-Y, Gu W, Kim K-A, Jang S-E, Han MJ, Kim D-H. Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a d-galactose-induced accelerated aging mouse model. Anaerobe. 2014;27:22-6. doi:10.1016/j.anaerobe.2014.03.003.
163. Tubelius P, Stan V, Zachrisson A. Increasing work-place healthiness with the probiotic lactobacillus reuteri: a randomised, double-blind placebocontrolled study. Environ Health. 2005;4(1):25.
164. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut. 2010;60(3):307-17. doi:10.1136/gut.2009.202515.
165. Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015;48:258-64. doi:10.1016/j.bbi.2015.04.003.
166. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013;144(7):1394-401.e4. doi:10.1053/j.gastro.2013.02.043.
167. Mohammadi AA, Jazayeri S, Khosravi-Darani K, Solati Z, Mohammadpour N, Asemi Z et al. The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: a randomized, double-blind, placebocontrolled trial in petrochemical workers. Nutr Neurosci. doi:10.1179/1476830515Y.0000000023.
168. D'Mello C, Ronaghan N, Zaheer R, Dicay M, Le T, MacNaughton WK, et al. Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J Neurosci. 2015;35(30):10821-30.
169. Jeong J, Kim K, Ahn Y, Sim J, Woo J, Huh C, et al. Probiotic mixture KF attenuates age-dependent memory deficit and lipidemia in Fischer 344 rats. J Microbiol Biotechnol. 2015;25(9):1532-6. doi:10.4014/jmb.1505.05002.
170. Davari S, Talaei SA, Alaei H, Salami M. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience. 2013;240:287-96. doi:10.1016/j.neuroscience.2013.02.055.
171. Gilbert K, Arseneault-Bréard J, Flores Monaco F, Beaudoin A, Bah TM, Tompkins TA, et al. Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion. Br J Nutr. 2013;109(01):50-6. doi:10.1017/S0007114512003807.